Lipid and Lipoprotein Responses to Oral Combined Hormone Replacement Therapy in Normolipemic Obese Women with Controlled Type 2 Diabetes Mellitus

This study investigated the effects of oral combined hormone replacement therapy (OCHRT) on lipid concentrations and subpopulation distribution of lipoproteins in nine postmenopausal women with type 2 diabetes mellitus and moderate glycemic control. After 16 weeks of continuous daily therapy of conjugated estrogens 0.625 mg and medroxyprogesterone 2.5 mg, the mean concentration of high‐density lipoprotein (HDL) cholesterol showed a statistically significant increase of 16.7%, predominantly in the HDL2 subfraction. No statistically significant changes in mean concentrations of total cholesterol, low‐density lipoprotein (LDL) cholesterol, triglycerides, very low‐density lipoprotein (VLDL) triglycerides, apolipoprotein A1, or apolipoprotein B were evident. Likewise, no changes were found in the average diameter of VLDL, LDL, or HDL particles; triglyceride concentrations of VLDL subfractions; cholesterol concentrations of LDL subfractions; or chemical composition of plasma LDL. These findings lend further support to the use of OCHRT in postmenopausal women with diabetes to decrease their risk for coronary artery disease.

• Publication year

  1998

• Venue

  Journal of clinical pharmacology

• Publication date

  1998-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/009127009803801204PMID 11301562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus.

  1997cited by this paper
• Lipids and lipoproteins in women.

  1997cited by this paper
• Effect of 17β-Estradiol on Plasma Lipids and LDL Oxidation in Postmenopausal Women With Type II Diabetes Mellitus

  1997cited by this paper
• A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.

  1996cited by this paper
• Lipoprotein metabolism in non-insulin-dependent diabetes mellitus

  1996cited by this paper
• Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

  1996cited by this paper
• Coronary artery disease in women.

  1996cited by this paper
• Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

  1996cited by this paper
• Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.

  1996cited by this paper
• Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group.

  1996cited by this paper
• Adverse change in low-density lipoprotein subfractions profile with oestrogen-only hormone replacement therapy.

  1996cited by this paper
• Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes.

  1996cited by this paper
• Effect of postmenopausal estrogen replacement therapy on lipoproteins

  1996cited by this paper
• Can Postmenopausal Hormone Replacement Improve Plasma Lipids in Women With Diabetes?

  1996cited by this paper
• Different effects of continuous oestrogen–progestin and transdermal oestrogen with cyclic progestin regimens on low‐density lipoprotein subclasses

  1996cited by this paper
• Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.

  1995cited by this paper
• The primary prevention of coronary heart disease in women.

  1995cited by this paper
• LDL density and atherosclerosis.

  1995cited by this paper
• Lipids, lipoproteins, women and cardiovascular disease.

  1994cited by this paper
• The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.

  1994cited by this paper
• Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.

  1994cited by this paper
• Insulin and lipoprotein metabolism with special reference to the diabetic state.

  1994cited by this paper
• Low-density lipoprotein density and atherosclerosis. Unraveling the connection.

  1994cited by this paper
• Changes in the low-density lipoprotein profile during 17 beta-estradiol-dydrogesterone therapy in postmenopausal women.

  1994cited by this paper
• Estrogens, lipids, and heart disease.

  1993cited by this paper
• Microplate methods for determination of serum cholesterol, high density lipoprotein cholesterol, triglyceride and apolipoproteins

  1993cited by this paper
• Lipoprotein Abnormalities in Well-Treated Type II Diabetic Patients

  1993cited by this paper
• Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

  1993cited by this paper
• Coronary Artery Disease in Women: Risk Factors, Evaluation, Treatment, and Prevention

  1993cited by this paper
• Association of Hormone-Replacement Therapy With Various Cardiovascular Risk Factors in Postmenopausal Women

  1993cited by this paper
• Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.

  1993cited by this paper
• Response of plasma low density lipoprotein subfractions to oestrogen replacement therapy following surgical menopause

  1993cited by this paper
• George Lyman Duff Memorial Lecture. Atherogenesis in diabetes.

  1992cited by this paper
• Low density lipoprotein particle size and coronary artery disease.

  1992cited by this paper
• LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes.

  1992cited by this paper
• A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus.

  1992cited by this paper
• Postmenopausal estrogen therapy and cardiovascular disease.

  1992cited by this paper
• Postmenopausal estrogen therapy and cardiovascular disease.

  1992cited by this paper
• Atherogenesis in diabetes

  1992cited by this paper
• Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.

  1991cited by this paper
• Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

  1991cited by this paper
• Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women.

  1991cited by this paper
• A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women.

  1991cited by this paper
• Influence of Obesity, Impaired Glucose Tolerance, and NIDDM on LDL Structure and Composition: Possible Link Between Hyperinsulinemia and Atherosclerosis

  1990cited by this paper
• Alterations in low-density lipoproteins in subjects with abdominal adiposity.

  1989cited by this paper
• Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin.

  1989cited by this paper
• The place of HDL in cholesterol management. A perspective from the National Cholesterol Educational Program.

  1989cited by this paper
• Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women.

  1988cited by this paper
• Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes

  1988cited by this paper
• Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study.

  1988cited by this paper
• Low density lipoprotein metabolism in non-insulin-dependent diabetes mellitus.

  1987cited by this paper
• HDL metabolism in diabetes.

  1987cited by this paper
• Menopause and the risk of coronary heart disease in women.

  1987cited by this paper
• Lipoprotein metabolism in diabetes mellitus.

  1987cited by this paper
• Very low density lipoprotein metabolism in diabetes mellitus.

  1987cited by this paper
• Metabolic risk factors for coronary heart disease in women: perspective from the Framingham study

  1987cited by this paper
• Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein.

  1987cited by this paper
• Effects of NIDDM on Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B Metabolism: Studies Before and After Sulfonylurea Therapy

  1986cited by this paper
• Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus.

  1986cited by this paper
• Moderate weight loss and sulfonylurea treatment of non-insulin-dependent diabetes mellitus. Combined effects.

  1985cited by this paper
• A prospective study of postmenopausal estrogen therapy and coronary heart disease.

  1985cited by this paper
• Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.

  1985cited by this paper
• Improvement of the Plasma Lipoprotein Pattern After Institution of Insulin Treatment in Diabetes Mellitus

  1982cited by this paper
• Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy.

  1982cited by this paper
• The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal

  1978cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?

  2017influential citation
• "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.

  2011cites this paper
• Glucose and Lipid Metabolism

  2011cites this paper
• The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.

  2006cites this paper
• Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.

  2005cites this paper
• Soy leaf lowers the ratio of non-HDL to HDL cholesterol in hamsters.

  2003cites this paper
• Effects of tibolone and conjugated equine estrogens with or without medroxyprogesterone acetate on body composition and fasting carbohydrate measures in surgically postmenopausal monkeys.

  2003cites this paper
• Hormone Replacement Therapy in Postmenopausal Women with Diabetes Mellitus

  2002cites this paper
• HRT in women with diabetes--review of the effects on glucose and lipid metabolism.

  2001cites this paper